Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2013 | 2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells | Kuo K.-L.; Lin W.-C.; Ho I.-L.; Chang H.-C.; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; KUO-HOW HUANG | PLoS ONE | 24 | 19 | |
2013 | 2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells | Kuo K.-L.; Lin W.-C.; Ho I.-L.; HONG-CHIANG CHANG ; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; Huang K.-H. | PLoS ONE | 24 | 19 | |
2013 | 2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells | Kuo K.-L.; WEI-CHOU LIN ; Ho I.-L.; Chang H.-C.; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; Huang K.-H. | PLoS ONE | 24 | 19 | |
2008 | Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma | Lin C.-C.; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; ANN-LII CHENG ; Yang C.-H. | Urologic Oncology: Seminars and Original Investigations | 8 | 7 | |
2008 | Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma | Lin C.-C.; Pu Y.-S.; CHIH-HUNG HSU ; Keng H.-Y.; Cheng A.-L.; Yang C.-H. | Urologic Oncology: Seminars and Original Investigations | 8 | 7 | |
2021 | Additive effects of arsenic and aristolochic acid in chemical carcinogenesis of upper urinary tract urothelium | Chen C.-H.; Grollman A.P.; CHAO-YUAN HUANG ; Shun C.-T.; Sidorenko V.S.; Hashimoto K.; Moriya M.; Turesky R.J.; Yun B.H.; Tsai K.; Wu S.; Chuang P.-Y.; Tang C.-H.; Yang W.-H.; Tzai T.-S.; Tsai Y.-S.; Dickman K.G.; Pu Y.-S. | Cancer Epidemiology Biomarkers and Prevention | 4 | 2 | |
2021 | Additive effects of arsenic and aristolochic acid in chemical carcinogenesis of upper urinary tract urothelium | Chen C.-H.; Grollman A.P.; Huang C.-Y.; CHIA-TUNG SHUN ; Sidorenko V.S.; Hashimoto K.; Moriya M.; Turesky R.J.; Yun B.H.; Tsai K.; Wu S.; Chuang P.-Y.; Tang C.-H.; Yang W.-H.; Tzai T.-S.; Tsai Y.-S.; Dickman K.G.; Pu Y.-S. | Cancer Epidemiology Biomarkers and Prevention | 4 | 2 | |
2018 | Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma | Hsueh Y.-M.; Chen W.-J.; Lin Y.-C.; CHAO-YUAN HUANG ; Shiue H.-S.; Yang S.-M.; Ao P.-L.; Pu Y.-S.; Su C.-T. | Toxicology and Applied Pharmacology | 12 | 11 | |
2018 | Adjuvant androgen-deprivation therapy following prostate total cryoablation in high-risk localized prostate cancer patients — Open-labeled randomized clinical trial | CHUNG-HSIN CHEN ; Pu Y.-S. | Cryobiology | 1 | 1 | |
2017 | Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle | Tseng C.-S.; CHIANG I-NI ; Hong C.-H.; Lu Y.-C.; Hong J.-H.; Chang H.-C.; Huang K.-H.; Pu Y.-S. | Scientific Reports | 10 | 11 | |
2017 | Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle | CHI-SHIN TSENG ; Chiang I.-N.; Hong C.-H.; Lu Y.-C.; Hong J.-H.; Chang H.-C.; Huang K.-H.; Pu Y.-S. | Scientific Reports | 10 | 12 | |
2017 | Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle | Tseng C.-S.; Chiang I.-N.; Hong C.-H.; YU-CHUAN LU ; Hong J.-H.; Chang H.-C.; Huang K.-H.; Pu Y.-S. | Scientific Reports | 10 | 12 | |
2017 | Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle | Tseng C.-S.; Chiang I.-N.; Hong C.-H.; Lu Y.-C.; Hong J.-H.; Chang H.-C.; KUO-HOW HUANG ; Pu Y.-S. | Scientific Reports | 10 | 12 | |
2017 | Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle | Tseng C.-S.; Chiang I.-N.; Hong C.-H.; Lu Y.-C.; JIAN-HUA HONG ; Chang H.-C.; Huang K.-H.; Pu Y.-S. | Scientific Reports | 10 | 11 | |
2017 | Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle | Tseng C.-S.; Chiang I.-N.; Hong C.-H.; Lu Y.-C.; Hong J.-H.; HONG-CHIANG CHANG ; Huang K.-H.; Pu Y.-S. | Scientific Reports | 10 | 12 | |
2017 | Analysis of transrectal and suprapubic ultrasonography for prostate size evaluation | Feng K.-K.; Chiang I.-N.; CHAO-YUAN HUANG ; Pu Y.-S. | Urological Science | 1 | 2 | |
2017 | Analysis of transrectal and suprapubic ultrasonography for prostate size evaluation | Feng K.-K.; CHIANG I-NI ; Huang C.-Y.; Pu Y.-S. | Urological Science | 1 | 2 | |
1999 | Antiandrogen hepatotoxicity in patients with chronic viral hepatitis | Pu Y.-S.; Liu C.-M.; JIA-HORNG KAO ; Chen J.; Lai M.-K. | European Urology | 22 | 13 | |
2019 | The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center | Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; SHIH-PING LIU ; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Hung S.-C.; Huang C.-Y. | Journal of the Formosan Medical Association | 5 | 5 | |
2019 | The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center | Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; YI-KAI CHANG ; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Hung S.-C.; Huang C.-Y. | Journal of the Formosan Medical Association | 5 | 5 |